Haihui Sheng
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
Papers in
-
- Circular RNAs in diseases 7
- Cancer-related gene regulation 6
- Ubiquitin and proteasome pathways 3
-
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 8
- Co-authors
- Hengjun Gao (20 shared papers)Junxing Huang (9 shared papers)Hong Yu (11 shared papers)Chengzhi He (8 shared papers)Kun Tao (2 shared papers)Bensong Duan (8 shared papers)Maosong Lin (3 shared papers)Yuemei Hu (1 shared paper)
- Journals
- Medicine (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Microbial Drug Resistance (1 paper)Cancer Medicine (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Haihui Sheng
52 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 89
- Cancer Research 506
- Molecular Biology 616
- Oncology 141
- Cardiology and Cardiovascular Medicine 100
- Immunology 76
Countries citing papers authored by Haihui Sheng
This map shows the geographic impact of Haihui Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haihui Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haihui Sheng more than expected).
Fields of papers citing papers by Haihui Sheng
This network shows the impact of papers produced by Haihui Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haihui Sheng. The network helps show where Haihui Sheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Haihui Sheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic value of miR-221-3p, miR-342-3p and miR-491-5p expression in colon cancer. | 2014 | 95 |
| 2 | 2016 | 67 | |
| 3 | 2016 | 63 | |
| 4 | 2006 | 60 | |
| 5 | 2019 | 57 | |
| 6 | 2008 | 55 | |
| 7 | 2013 | 53 | |
| 8 | Activation of the Wnt pathway through Wnt2 promotes metastasis in pancreatic cancer. | 2014 | 50 |
| 9 | Aberrant expression of microRNAs in serum may identify individuals with pancreatic cancer. | 2014 | 50 |
| 10 | MicroRNA-139-3p indicates a poor prognosis of colon cancer. | 2014 | 43 |
| 11 | UNC51-like kinase 1 as a potential prognostic biomarker for hepatocellular carcinoma. | 2013 | 41 |
| 12 | Long non-coding RNA expression profile in atrial fibrillation. | 2015 | 40 |
| 13 | 2012 | 36 | |
| 14 | Serum miR-200c and clinical outcome of patients with advanced esophageal squamous cancer receiving platinum-based chemotherapy. | 2013 | 34 |
| 15 | Expression and prognostic value of c-Myc and Fas (CD95/APO1) in patients with pancreatic cancer. | 2014 | 29 |
| 16 | Association of nuclear annexin A1 with prognosis of patients with esophageal squamous cell carcinoma. | 2014 | 27 |
| 17 | 2019 | 24 | |
| 18 | 2017 | 24 | |
| 19 | ERCC1 C118T associates with response to FOLFOX4 chemotherapy in colorectal cancer patients in Han Chinese. | 2012 | 21 |
| 20 | 2014 | 20 |
About Haihui Sheng
Haihui Sheng is a scholar working on Molecular Biology, Cancer Research, Oncology, Surgery and Genetics, having authored 52 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (7 papers), Cancer-related gene regulation (6 papers), Genetic Associations and Epidemiology (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), Ubiquitin and proteasome pathways (3 papers) and Galectins and Cancer Biology (3 papers). The work is most often cited by research in Cancer Research (506 citations), Molecular Biology (616 citations), Oncology (141 citations), Cardiology and Cardiovascular Medicine (100 citations) and Immunology (76 citations). Haihui Sheng has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Hengjun Gao, Junxing Huang, Hong Yu, Chengzhi He, Kun Tao, Bensong Duan, Maosong Lin, Yuemei Hu, Zhenhua Guo and Jing Yang. Their work appears in journals such as Medicine, Cancer Chemotherapy and Pharmacology, Microbial Drug Resistance, Cancer Medicine and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.